ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

ClinicalTrials.gov ID: NCT06611553

Public ClinicalTrials.gov record NCT06611553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

NCI Cervical Cancer 'Last Mile' Initiative 'Self-Collection for HPV Testing to Improve Cervical Cancer Prevention' (SHIP) Trial LMI-001-A-S02

Study identification

NCT ID
NCT06611553
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
500 participants

Conditions and interventions

Interventions

  • Biospecimen Collection Procedure
  • Cervical Biopsy Procedure
  • Colposcopy Procedure
  • Electronic Health Record Review Other
  • Endocervical Curettage Procedure
  • Excision Procedure
  • HPV Self-Collection Procedure
  • Human Papillomavirus Test Procedure
  • Questionnaire Administration Other
  • Survey Administration Other

Procedure · Other

Eligibility (public fields only)

Age range
25 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 12, 2024
Primary completion
Jun 29, 2026
Completion
Dec 30, 2026
Last update posted
Apr 28, 2026

2024 – 2026

United States locations

U.S. sites
13
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233
Yale University New Haven Connecticut 06520
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136
Louisiana State University Health Science Center New Orleans Louisiana 70112
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287
University of Mississippi Medical Center Jackson Mississippi 39216
NYP/Weill Cornell Medical Center New York New York 10065
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599
Cleveland Clinic Foundation Cleveland Ohio 44195
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
University of Pennsylvania/Abramson Cancer Center Philadelphia Pennsylvania 19104
UPMC-Magee Womens Hospital Pittsburgh Pennsylvania 15213
VCU Massey Comprehensive Cancer Center Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06611553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06611553 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →